Effect of Inulin on Gut Microbiota and Gut Barrier in Chronic Kidney Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorCharite University, Berlin, Germany

About this trial

An adequate fiber intake is crucial for a well-balanced diet and reduces the risk of chronic diseases. However, nutritional recommendations for chronic kidney disease patients lead to an insufficient fiber intake with possible maladaptive effects on the gut microbiome. Therefore, we want to study the effects of a 35-day inulin supplementation on the gut microbiome, gut barrier function, bacterial metabolites and immune cell states in chronic kidney disease patients.

Eligibility criteria

Qualifiers

Men and women in a ratio of 1:1

Age 18-75 years

Body mass index 25.0 - 39.9 kg/m²

End-stage kidney disease, which has been treated regularly with hemodialysis for at least 3 months

Disqualifiers

Malignant diseases

Recent or current hospitalization

Postoperative phase

Acute infections

Trial design

Treatments tested in this trial

  • Inulin
  • Placebo

Treatment groups

40 Participants
are divided into 2 treatment groups